Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Yeast Recombinant Lipase,Undisclosed
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : First Wave BioPharma
Deal Size : Undisclosed
Deal Type : Agreement
Details : Creapharm will package, label, and distribute AzurRx’s MS1819 clinical trial drug product for both the upcoming Phase 2b OPTION 2 Monotherapy and the ongoing Phase 2 Combination Therapy Programs.
Product Name : MS1819
Product Type : Enzyme
Upfront Cash : Undisclosed
July 05, 2020
Lead Product(s) : Yeast Recombinant Lipase,Undisclosed
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : First Wave BioPharma
Deal Size : Undisclosed
Deal Type : Agreement